For a long time, patients suffering from non-melanoma skin cancers such as basal cell carcinoma and squamous cell carcinoma only had one option to turn to for successful treatment. Mohs surgery, developed by general surgeon Frederik E. Mohs in 1938, involves removing one thin layer of tissue from the afflicted area at a time and […]
SRT-100 Vision featured on San Antonio News
SRT-100 Vision a New Technology Revolutionizing Skin Cancer Treatment Skin cancer—it’s the most common cancer in the United States. An estimated one in five Americans will develop skin cancer in their lifetimes, but there’s a new technology that’s revolutionizing how patients are treated and it’s in the San Antonio area. “I’ve had skin cancers now […]
Superficial radiation therapy offers an effective alternative to Mohs surgery
Dr. David Goldberg spoke at the 2017 South Beach Symposium conference on how SRT technology has rapidly advanced in the past 30 years and how SRT is an effective way to eradicate tumors while maintaining or improving patients’ quality of life. Below is an excerpt from the article by Healio.com covering this presentation: MIAMI — Superficial […]
Superficial radiation therapy provides safe, aesthetic results for non-melanoma skin cancer patients
MIAMI — At South Beach Symposium 2017, symposium chairman Mark S. Nestor, MD, PhD, discusses the efficacy and cosmetic benefits of superficial radiation therapy to treat both non-melanoma skin cancer and recurring keloid scars. Nestor presented at the symposium on innovative breakthroughs in superficial radiation therapy, including new technology from Sensus Healthcare. To watch the […]
Sensus Healthcare to Participate in 2017 South Beach Symposium on February 9 – 12 in Miami
— Joe Sardano, Sensus Healthcare CEO, to Participate in CEO Forum on February 11 — Sensus Healthcare Medical Advisory Board Members to Host SRT Workshops on February 9 BOCA RATON, Fla., Feb. 7, 2017 — Sensus Healthcare, Inc. (NASDAQ: SRTS), a medical device company specializing in the treatment of non-melanoma skin cancers and other skin […]
Sensus Healthcare Reports Fourth Quarter and Full Year 2016 Results
– Record Quarterly Revenues of $4.9 million in Fourth Quarter – Full Year 2016 revenues increased 44% year-over-year to $14.8 million – Worldwide installed base increased to 271 units BOCA RATON, Fla., Feb. 2, 2017 — Sensus Healthcare, Inc. (NASDAQ: SRTS), a medical device company specializing in the treatment of non-melanoma skin cancers and other […]
Sensus Healthcare to Announce Fourth Quarter and Full Year 2016 Results on February 2, 2017
BOCA RATON, Fla., Jan. 19, 2017 — Sensus Healthcare, Inc. (NASDAQ: SRTS), a medical device company specializing in the treatment of non-melanoma skin cancers and other skin conditions, such as keloids, with superficial radiation therapy, today announced that it will report its fourth quarter and full year 2016 financial results on Thursday, February 2, 2017 […]
SRT-100™: The Doctor’s Choice for Treatment of Non-Melanoma Basal Cell Cancer
Giving a skin cancer diagnosis to a patient is never easy. The word “cancer” is a scary word for any patient to hear. Sadly, one in five Americans will develop skin cancer over the course of their lifetime and 40 to 50 percent of Americans who live to age 65 will have either basal cell […]
Sensus Healthcare to Participate in Annual JP Morgan Healthcare Conference Week on January 9th – 11th in San Francisco
BOCA RATON, Fla., Jan. 3, 2017 — Sensus Healthcare, Inc. (NASDAQ: SRTS), a medical device company specializing in the treatment of non-melanoma skin cancers (NMSC) and other skin conditions such as keloids with superficial radiation therapy (SRT), today announced that Joe Sardano, CEO and Arthur Levine, CFO will participate in the Annual JP Morgan Healthcare […]
Sensus Healthcare CEO Shares A Look Into Skin Cancer Treatment
Sensus Healthcare Inc (NASDAQ: SRTS) (NASDAQ: SRTSU) is micro-cap manufacturer of superficial radiation therapy (SRT) devices for the treatment of skin cancer and keloids, which went public on the Nasdaq exchange in June. Benzinga recently had the chance to chat with the company’s CEO Joseph C. Sardano, who shared some insight into the company and […]
Do You Have a Keloid Scar?
If you have a scar that doesn’t seem to be fading, or even appears to be growing in size, it is important to determine whether that scar is a keloid or not. There are two types of raised scars: keloid and hypertrophic. While both hypertrophic scars and keloid scars themselves are benign, the uncontrolled growth […]
Sensus Healthcare Receives the BioFlorida Company of the Year Award
BOCA RATON, Fla., Dec. 13, 2016 — Sensus Healthcare, Inc. (NASDAQ: SRTS), a medical device company specializing in the treatment of non-melanoma skin cancers (NMSC) and other skin conditions such as keloids with superficial radiation therapy (SRT), announced today that it has been named the winner of the BioFlorida Company of the Year Award at […]
Regain Your Confidence with Non-Surgical Treatment for Your Keloid Scar
If you are one of the nearly 18 million people affected by ugly and sometimes painful keloid scars, you know first-hand just how embarrassing they can be. We have good news for you. You can regain your confidence with SRT therapy, a non-surgical option for treating keloid scars after surgical removal. What Causes a Keloid […]
Sensus Healthcare to Participate in Two Upcoming Investor Conferences on November 30th and December 1st
— Evercore ISI MedTools Investor Conference in Boston, MA — Drexel Hamilton’s Emerging Growth Conference in New York, NY BOCA RATON, Fla., Nov. 16, 2016 — Sensus Healthcare, Inc. (NASDAQ: SRTS), a medical device company specializing in the treatment of non-melanoma skin cancers and other skin conditions, such as keloids, with superficial radiation therapy (SRT), […]
Sensus Healthcare Reports Third Quarter 2016 Results
– Q3 revenues increased 58% year-over-year to $3.33 million – Worldwide installed base increased to 256 units BOCA RATON, Fla., Nov. 3, 2016 — Sensus Healthcare, Inc. (NASDAQ: SRTS), a medical device company specializing in the treatment of non-melanoma skin cancers and other skin conditions, such as keloids, with superficial radiation therapy (SRT), today reported […]
Patients Benefit from Non-Surgical SRT
If you’ve been diagnosed with non-melanoma skin cancer, such as basal cell carcinoma or squamous cell carcinoma, you now have a new, non-surgical option for treatment. Superficial Radio Therapy (SRT) with the SRT-100™ delivers a precise, calibrated dose of SRT that only goes skin deep. This low-dose of Superficial Radio Therapy safely destroys non-melanoma skin […]
Physicians Prefer SRT Therapy for Treatment of Non-Melanoma Skin Cancer and Keloid Scars
Eighteen million people are affected by unsightly and sometimes painful keloid scars, and many of them go through life believing treatment for this embarrassing condition is next to impossible, if possible at all. You can help restore your patient’s confidence and self-esteem by offering keloid treatment with Superficial Radio Therapy (SRT therapy) following surgical removal. […]
Sensus Healthcare to Announce Third Quarter 2016 Results on November 3, 2016
BOCA RATON, Fla., Oct. 20, 2016 — Sensus Healthcare, Inc. (NASDAQ: SRTS), a medical device company specializing in the treatment of non-melanoma skin cancers and other skin conditions, such as keloids, with superficial radiation therapy, today announced that it will report its third quarter 2016 financial results on Thursday, November 3, 2016 after the market […]
New study highlights need for routine skin cancer screening for all transplant patients
Drexel University College of Medicine study suggests all organ transplant recipients should receive total-body screenings for skin cancer
Sensus Healthcare to Participate in Important Dermatological and Institutional Investor Conferences from October 20th to October 23rd
–2016 Fall Clinical Dermatology Conference in Las Vegas, NV –Dawson James 2016 Small Cap Growth Stock Conference in Jupiter, FL BOCA RATON, Fla., Oct. 6, 2016 — Sensus Healthcare, Inc. (NASDAQ: SRTS), a medical device company specializing in the treatment of non-melanoma skin cancers and other skin conditions, such as keloids, with superficial radiation therapy […]